Today: 15 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

CrowdStrike stock jumps 6% as Cantor sticks with $590 target and CRWD leads cyber rally

CrowdStrike stock jumps 6% as Cantor sticks with $590 target and CRWD leads cyber rally

CrowdStrike shares rose 5.6% to $483.88 Wednesday, leading gains in cybersecurity stocks after ADP data showed weaker-than-expected U.S. private payroll growth. Cantor Fitzgerald reiterated an Overweight rating and $590 target, citing strong subscription momentum. CrowdStrike, Amazon Web Services, and Nvidia launched a cybersecurity startup accelerator focused on AI. Investors await Friday’s U.S. jobs report and CrowdStrike’s fiscal year-end.
7 January 2026
··
Coinbase stock slips as bitcoin cools and Wall Street checks the fine print

Coinbase stock slips as bitcoin cools and Wall Street checks the fine print

Coinbase shares fell 1.6% to $246.50 by midday Wednesday as bitcoin and ether prices declined. Director Fred Wilson sold 10,000 shares for about $2.34 million under a pre-set plan, a filing showed. Analyst opinions split on whether Coinbase’s trading volumes are dropping too quickly. Morgan Stanley filed to launch bitcoin and solana ETFs, while Barclays invested in stablecoin startup Ubyx.
7 January 2026
···
Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard stock rises as Morgan Stanley flags cross-border strength ahead of U.S. jobs report

Mastercard shares rose 0.7% to $584.60 by midday Wednesday, outperforming Visa, which slipped 0.4%. Morgan Stanley maintained an “overweight” rating, citing growth in cross-border fees and security services. About 1.36 million Mastercard shares traded as investors watched for Friday’s U.S. jobs report and the Jan. 9 dividend record date. U.S. private payrolls rose less than expected in December, ADP reported.
7 January 2026
·
Uber stock gains as CES robotaxi testing update puts autonomy back in focus

Uber stock gains as CES robotaxi testing update puts autonomy back in focus

Uber shares rose 1.7% to $87.03 in midday New York trading after unveiling a robotaxi partnership with Lucid and Nuro at CES. The companies began autonomous road testing in December and plan a San Francisco Bay Area launch later in 2026. Lucid shares fell 5%, while Nvidia gained 1.6%. Investors are watching for regulatory updates and Uber’s February earnings report.
7 January 2026
····
Intel stock jumps 8% on CES 2026 18A chip debut as INTC investors eye the next catalyst

Intel stock jumps 8% on CES 2026 18A chip debut as INTC investors eye the next catalyst

Intel shares rose 8.3% to $43.37 Wednesday after unveiling laptop chips built on its new 18A process at CES in Las Vegas. The company said preorders for laptops using the chips start Jan. 6, with shipments beginning Jan. 27. Melius Research upgraded Intel to “buy” and set a $50 target. Intel outperformed rivals as the iShares Semiconductor ETF fell 1.2% and AMD dropped 2.3%.
7 January 2026
·
Exxon Mobil stock slides as Trump’s Venezuela oil plan drags crude, filing due after close

Exxon Mobil stock slides as Trump’s Venezuela oil plan drags crude, filing due after close

Exxon Mobil shares fell 1.1% to $119.71 Wednesday as oil prices dropped after President Trump said Venezuela would send up to 50 million barrels of sanctioned oil to the U.S. Brent crude slipped 0.7% to near $60 a barrel. Exxon is set to release a fourth-quarter “earnings considerations” 8-K after market close. Trump plans to meet oil executives later this week to discuss Venezuela.
7 January 2026
··
Eli Lilly stock climbs on Ventyx buyout talk as dealmaking takes center stage

Eli Lilly stock climbs on Ventyx buyout talk as dealmaking takes center stage

Eli Lilly shares rose 3.3% to $1,099.44 after reports it is in advanced talks to buy Ventyx Biosciences for over $1 billion, according to the Wall Street Journal. The news follows Lilly’s new obesity-drug partnership with Nimbus and comes as Novo Nordisk launches an oral Wegovy pill in the U.S. Investors await updates at next week’s J.P. Morgan healthcare conference and Lilly’s upcoming earnings call.
7 January 2026
·
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings

UnitedHealth shares fell over 2% to $340.44 Wednesday morning, erasing part of Tuesday’s gain. The drop followed analyst moves, with Bernstein raising its target to $444 and Evercore ISI starting coverage at $400. Investors await UnitedHealth’s Jan. 27 results and Medicare Advantage rate updates. Humana and Cigna also declined.
7 January 2026
·······
Google (Alphabet) GOOG stock rises as House tees up self-driving hearing; Waymo in focus

Google (Alphabet) GOOG stock rises as House tees up self-driving hearing; Waymo in focus

Alphabet Class C shares climbed 1.7% to $319.98 in morning trading Wednesday, outperforming a mixed U.S. market. A U.S. House subcommittee set a Jan. 13 hearing on draft bills to ease deployment of driverless vehicles, including raising the exemption cap to 90,000 per year. CES in Las Vegas drew attention to autonomous tech and AI, with Waymo and Nvidia in focus.
7 January 2026
··
1 … 372 373 374 375 376 … 704

Stock Market Today

  • Pan American Silver's La Colorada Discoveries and Buyback Plan Impact Investment Case
    March 15, 2026, 1:21 AM EDT. Pan American Silver Corp. announced high-grade silver vein discoveries at its La Colorada mine in Mexico, expected to influence the 2026 mineral reserve update. The company also approved a share repurchase program of up to 5% of outstanding shares through 2027, signaling a focus on capital returns amid strong earnings. While the new silver finds enhance resource depth, they do not immediately affect production or costs, keeping the investment case centered on long-term cash flow from a diversified portfolio. Despite a recent share price decline, analysts' fair value estimates vary widely, reflecting uncertainty about the impact of these developments. Investors face risks including metal price volatility, project execution, and elevated valuations following strong multi-year stock performance.
Go toTop